About Octant
Octant is a company based in Los Angeles (United States) founded in 2017. It operates as a HealthTech. Octant has raised $110 million across 4 funding rounds from investors including HHS, Allen & Company and Bristol-Myers Squibb. The company has 63 employees as of December 31, 2024. Octant offers products and services including OCT-980 and Genetic Disease Correctors. Octant operates in a competitive market with competitors including DNAnexus, Arbor Biotechnologies, Cytel, Verge Genomics and Singleron, among others.
- Headquarter Los Angeles, United States
- Employees 63 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Octant, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$110 M (USD)
in 4 rounds
-
Latest Funding Round
$80 M (USD), Series B
Apr 21, 2022
-
Investors
HHS
& 7 more
-
Employee Count
63
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Octant
Octant offers a comprehensive portfolio of products and services, including OCT-980 and Genetic Disease Correctors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Designed to correct protein misfolding in retinal disorders.
Developed to address protein misfolding in genetic diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Octant
Octant has successfully raised a total of $110M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $80 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $80.0M
-
First Round
First Round
(01 May 2020)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series B - Octant | Valuation | Catalio Capital Management | |
| Apr, 2021 | Amount | Grant - Octant | Valuation |
investors |
|
| May, 2020 | Amount | Series A - Octant | Valuation | a16z |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Octant
Octant has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Allen & Company and Bristol-Myers Squibb. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Octant
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Octant
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Octant Comparisons
Competitors of Octant
Octant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Arbor Biotechnologies, Cytel, Verge Genomics and Singleron, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease drugs are developed using computational genomics.
|
|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Octant
Frequently Asked Questions about Octant
When was Octant founded?
Octant was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Octant located?
Octant is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Is Octant a funded company?
Octant is a funded company, having raised a total of $110M across 4 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on May 01, 2020.
How many employees does Octant have?
As of Dec 31, 2024, the latest employee count at Octant is 63.
What does Octant do?
Octant is engaged in developing next-generation small molecule therapeutics by merging biology, chemistry, and computation. The company targets complex cellular mechanisms to address diseases caused by protein misfolding and mistrafficking. Solutions are built to deliver relief through innovative therapies, with a pipeline including treatments for retinitis pigmentosa, Fabry disease, and various cancers. Efforts are concentrated on precision medicine to transform drug discovery and clinical outcomes.
Who are the top competitors of Octant?
Octant's top competitors include DNAnexus, Arbor Biotechnologies and Cytel.
What products or services does Octant offer?
Octant offers OCT-980 and Genetic Disease Correctors.
Who are Octant's investors?
Octant has 8 investors. Key investors include HHS, Allen & Company, Bristol-Myers Squibb, Catalio Capital Management, and Andreessen Horowitz.